This 59-year-old man underwent implantation of a Boston Science Cognis triple chamber defibrillator in the context of severe ischemic cardiomyopathy with left bundle branch block. An episode of NSVT is diagnosed during a routine follow-up visit.
Summary
Episode diagnosed as NSVT.
Graph and tracing
Second tracing
This tracing highlights the usual characteristics observed in patients presenting with electromagnetic interference, including
1) exposure to an emitting source at the time of the episode (in this patient a poorly insulated household appliance), and
2) short, regular, uninterrupted signals throughout the cardiac cycle. By changing the sweep speed, the Boston Scientific defibrillators enable the demonstration of a characteristic sinusoidal waveform with a 20-ms separation between each signal; in double or triple chamber defibrillators, the signals are usually visible on the atrial, the RV and LV and the high-voltage channels. Their amplitude is greater on the high-voltage than on the sensing channel. They are managed by a) identifying their source, and b) avoiding the use of poorly grounded devices.
A mode of response to noise can be programmed, which is activated when the noise is prolonged and diagnosed by the device. This algorithm is triggered by signals sensed in the noise window of the ventricular blanking period. The tracing displays the AN, VN, RVN or LVN noise markers, while the markers AP-Ns, VP-Ns, RVP-Ns and LVP-Ns indicate asynchronous pacing in response to the sensing of continuous noise. An asynchronous (AOO, VOO or DOO) or an inhibitory (OOO) pacing mode can also be programmed.